Cargando…
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
BACKGROUND: Breast cancer tumors are known to be highly heterogeneous and differences in their metabolic phenotypes, especially at protein level, are less well-understood. Profiling of metabolism-related proteins harbors the potential to establish new patient stratification regimes and biomarkers pr...
Autores principales: | Bernhardt, Stephan, Bayerlová, Michaela, Vetter, Martina, Wachter, Astrid, Mitra, Devina, Hanf, Volker, Lantzsch, Tilmann, Uleer, Christoph, Peschel, Susanne, John, Jutta, Buchmann, Jörg, Weigert, Edith, Bürrig, Karl-Friedrich, Thomssen, Christoph, Korf, Ulrike, Beissbarth, Tim, Wiemann, Stefan, Kantelhardt, Eva Johanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637318/ https://www.ncbi.nlm.nih.gov/pubmed/29020998 http://dx.doi.org/10.1186/s13058-017-0905-7 |
Ejemplares similares
-
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
por: Schüler, Kathleen, et al.
Publicado: (2022) -
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
por: Bauer, Marcus, et al.
Publicado: (2019) -
PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022) -
Profiling metabolic changes in breast cancer with targeted proteomics
por: Bernhardt, Stephan, et al.
Publicado: (2014) -
Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery
por: Wachter, Astrid, et al.
Publicado: (2015)